The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy

Clinical Hemorheology and Microcirculation

Volumn 39, Issue 1-4, 2008, Pages 385-389

  Vekasi, J ^a   Koltai, K ^a   Gaal, V ^a   Toth, A ^a   Juricskay, I ^a   Kesmarky, G ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Aspirin treatment; Diabetic retinopathy; Hemorheological parameters

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN;

ADULT; AGED; BLOOD RHEOLOGY; BLOOD VISCOSITY; CENTRIFUGE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; LABORATORY TEST; MALE; OPHTHALMOLOGY; PHYSICAL EXAMINATION; PLASMA VISCOSITY;

ADULT; AGED; ASPIRIN; BLOOD VISCOSITY; DIABETIC RETINOPATHY; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN; HEMATOCRIT; HEMORHEOLOGY; HUMANS; LASERS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS;

EID: 47849125662     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1106     Document Type: Conference Paper

References (17)

1. E.L. Bierman, Atherogenesis in diabetes, Arterioscler. Thromb. 12 (1992), 647-656.
2. A. Blann, A. Bignell and C. McCollum, Von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity, Atherosclerosis 139 (1998), 317-322.
3. J. Bozzo, M.R. Hernandez and A. Ordinas, Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin, Cardiovasc. Res. 30 (1995), 725-730.
4. B.I. Chazan, Microaneurysms in diabetes mellitus, Acta Diabet. Lat. 9 (1972), 337-349.
5. L. Dintenfass, Blood viscosity factors in severe nondiabetic and diabetic retinopathy, Biorheology 14 (1977), 151-157.
6. G. Feher, K. Koltai, E. Papp, B. Alkonyi, A. Solyom, P. Kenyeres, G. Kesmarky, L. Czopf and K. Toth, Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables, Drugs Aging 23 (2006), 559-567.
7. E.M. Hoare, A.J. Barnes and J.A. Dormandy, Abnormal blood viscosity in diabetes mellitus and retinopathy, Biorheology 13 (1976), 21-25.
8. W.B. Kannel, R.B. D'Agostino and A.J. Belanger, Update on fibrinogen as a cardiovascular risk factor, Ann. Epidemiol. 2 (1992), 457-466.
9. R. Klein, B.E.K. Klein, S.E.Moss, M.D. Davis and D.L. DeMets, The Wisconsin epidemiologic study of diabetic retinopathy. VI. Retinal photocoagulation, Ophthalmology 9 (1987), 747-753.
10. K. Koltai, G. Feher, Zs. Keszthelyi, P. Kenyeres, G. Kesmarky, J. Vekasi and K. Toth, Smoking and lower aspirin dosage are associated with higher prevalence of aspirin resistance in type-2 diabetic patients, Eur. Heart J. 27(Abstract Suppl.) (2006), 534.
11. K. Koltai, G. Feher, G. Kesmarky, Z. Keszthelyi, L. Czopf and K. Toth, The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests, Clin. Hemorheol. Microcirc. 35 (2006), 517-525.
12. G.D.O. Lowe, C.D. Forbes and W.S. Foulds, Hemorheology and retinal disorders, Clin. Hemorheol. 7 (1987), 181-188.
13. M.P. de Maat, Effects of diet, drugs, and genes on plasma fibrinogen levels, Ann. N.Y. Acad. Sci. 936 (2001), 509-521.
14. A. Marcinkowska-Gapinska and P. Kowal, Blood fluidity and thermography in patients with diabetes mellitus and coronary artery disease in comparison to healthy subjects, Clin. Hemorheol. Microcirc. 35 (2006), 473-479.
15. S. Shin, Y.H. Ku, J.X. Ho, Y.K. Kim, J.S. Suh and M. Singh, Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus, Clin. Hemorheol. Microcirc. 36 (2007), 253-261.
16. J. Vekasi, Zs. Marton, G. Kesmarky, A. Cser, R. Russai and B. Horvath, Hemorheological alterations in patients with diabetic retinopathy, Clin. Hemorheol. Microcirc. 24 (2001), 59-64.
17. D. Zilberman-Kravits, I. Harman-Boehm, T. Shuster and N. Meyerstein, Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes, Clin. Hemorheol. Microcirc. 35 (2006), 463-471.